- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03798873
Impact of the Use of FeelWell™ Compression Garment on Individuals With a BMI ≥35
Examining the Impact of the Use of a Custom-fitted, FeelWell™ Compression Garment to Improve the Quality of Life of Individuals With a BMI ≥35
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Individuals suffering with obesity often experience daily pain and discomfort which limits movement, a critical factor in managing weight, cardio-metabolic health, mood, sleep, self-esteem and ultimately overall quality of life. Many individuals who experience weight gain have an abdominal or central distribution of weight which affects body mechanics leading to back pain, poor posture, difficulty walking with altered gait, knee, foot, ankle and leg pain (IT band, meralgia paresthetica) and other non-specific chronic pain. Chronic pain impedes mobility often incorporating depression and low motivation in an endless cycle. Furthermore, as individuals are losing weight, they often suffer from excess skin which also aggravates by chafing (arms, inner thighs), hanging down and interfering with gait.
The Investigators will examine the effect of wearing a custom-fitted, FDA-registered, Class I device, compression garment (Obesinov, S.A.R.L.) by participants with a BMI ≥ 35 on day-to-day quality of life over a period of one year. Various measures of quality of life will be taken, including assessing the participant's level of pain, mood, self-stigma and comfort with the use of a compression garment. Additional assessments include impact of the compression garment on activity, strength, posture and movement as well as potential impact of the use of this garment on weight loss and change in laboratory measures of metabolic health.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Domenica Rubino, MD
- Phone Number: 17038070037
- Email: mvaughan@wtmgmt.com
Study Contact Backup
- Name: Rachel Trope, MS
- Phone Number: 7038070037
- Email: rtrope@wtmgmt.com
Study Locations
-
-
Virginia
-
Shirlington, Virginia, United States, 22206
- Recruiting
- Washington Center for Weight Management and Research, Inc.
-
Contact:
- Rachel Trope, MS
- Phone Number: 7038070037
- Email: rtrope@wtmgmt.com
-
Contact:
- Michelle Vaughan, MBA
- Phone Number: 703-807-0037
- Email: mvaughan@wtmgmt.com
-
Principal Investigator:
- Domenica Rubino, MD
-
Sub-Investigator:
- Rachel Trope, MS
-
Sub-Investigator:
- Mike Reing, MS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female, over 18 years old.
- Subjects with a BMI of ≥ 35.
- Subjects in any stage of weight loss or maintenance.
Exclusion Criteria:
- Inability to put on or have help in putting on garment.
- Inability to participate in movement and exercise intervention.
- Panniculus grade >3 at baseline or other body habitus that limits mobility.
- Duke Activity Status Index (DASI) score < 3.62
- Medical condition limiting participation in trial or basic mobility.
- Current participation in a physical therapy program.
- Unwillingness to participate fully in trial.
- Participation in another trial at the same time.
- Patient Health Questionnaire (PHQ)-9≥15.
- Current or expected pregnancy
- Investigator's discretion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: FeelWell™ Compression garment use with increase mobility
Subjects are randomized to wear custom-fitted FeelWell™ Compression garment daily during regular and exercise activities. Subjects will work with physical therapist and exercise physiologist to increase strength, mobility and activity. |
Registered FDA class I device: The FeelWell™ Compression garment is a custom-made orthopedic abdominal binder with full or half-body support. The garments are made of 70% polyamide and 30% elastane and OEKO-TEX certified confirming human-ecological safety of textiles. The company uses a wrap knitting to ensure an optimal compression and durability. The garment has two 360 degrees whalebones in the front and two in the back to provide support for the posture, reinforcing compression on the abdomen and lower-back.
Subjects will work with exercise physiologist and physical therapist to increase mobility, strength and activity
|
Other: Increase mobility
For the control group, subjects will work with physical therapist and exercise physiologist to increase strength, mobility and activity.
The control group will not be assigned a compression garment during the trial.
|
Subjects will work with exercise physiologist and physical therapist to increase mobility, strength and activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6- minute walk test- distance walked
Time Frame: baseline, 1, 3, 6 and 12 months
|
6-min walk test is a sub-maximal exercise test measuring the total distance walked by a subject in a period of 6 minutes to assess functional capacity of a subject's cardio-respiratory systems and reflects their ability to perform Activities of Daily Living.
Total distance walked will be measured and change recorded from baseline.
|
baseline, 1, 3, 6 and 12 months
|
6- minute walk test- Perceived exertion
Time Frame: baseline, 1, 3, 6 and 12 months
|
The Borg Rate of Perceived Exertion scale of 1-10 will be used for the subject to record their exertion level from 1 (no exertion)-10 (maximal exertion) and change will be noted from baseline.
|
baseline, 1, 3, 6 and 12 months
|
SF-36 physical component sub-score
Time Frame: baseline, 3, 6 and 12 months
|
SF-36 consists of 8 sub-scales of health-related quality of life measuring various aspects of functioning.
The summary score for physical component includes physical functioning, physical role, bodily pain and general health scores.
This sub-score is reported on a scale from 0-100 with higher numbers indicating better physical functioning.
|
baseline, 3, 6 and 12 months
|
30 Second Chair Stand
Time Frame: baseline, 1, 3, 6 and 12 months
|
A test of leg strength and endurance.
The number of times a patient stands from a sitting position in 30 seconds is recorded.
|
baseline, 1, 3, 6 and 12 months
|
Brief Pain Inventory-Interference sub-score
Time Frame: baseline, 1, 3, 6 and 12 months
|
A measure of pain and the interference of such pain on daily function.
A sub-score on a scale of 0 (no interference)- 10 (maximal interference) will be recorded.
The mean score of the 7 items will be recorded.
|
baseline, 1, 3, 6 and 12 months
|
Steps per day measured by accelerometer
Time Frame: baseline, 6 months and 1 year
|
The number of steps per day will be recorded as a measure of daily activity and averaged at various time points throughout the trial.
|
baseline, 6 months and 1 year
|
Weight Self Stigma questionnaire
Time Frame: baseline, 1, 3, 6 and 12 months
|
A questionnaire designed to explore both internalized self stigma (internalized self-devaluation) and enacted stigma (directly experienced stigma) on function will be administered.
The scale is comprised of 12 questions, and the subject responds on a scale from 1-5 with a greater score indicating greater experienced stigma.
|
baseline, 1, 3, 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lean body mass
Time Frame: baseline, 12 months
|
Using DXA (Dual-energy X-ray Absorptiometry), lean body mass (LBM) or fat-free mass will be measured at baseline and at end of study.
Percent change will be reported.
|
baseline, 12 months
|
Fat mass
Time Frame: baseline, 12 months
|
Using DXA (Dual-energy X-ray Absorptiometry), fat mass will be measured at baseline and at end of study.
Percent change will be reported.
|
baseline, 12 months
|
Bone density
Time Frame: baseline, 12 months
|
Using DXA (Dual-energy X-ray Absorptiometry), bone density will be measured at baseline and at end of study.
Percent change will be reported.
|
baseline, 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Domenica Rubino, MD, Washington Center for Weight Management and Research
Publications and helpful links
General Publications
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.
- Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins S. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med. 2006 Apr;100(4):658-65. doi: 10.1016/j.rmed.2005.08.003. Epub 2005 Oct 17.
- Grodin JL, Hammadah M, Fan Y, Hazen SL, Tang WH. Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J Card Fail. 2015 Jan;21(1):44-50. doi: 10.1016/j.cardfail.2014.08.013. Epub 2014 Aug 28.
- Jakicic JM, Rogers RJ, Davis KK, Collins KA. Role of Physical Activity and Exercise in Treating Patients with Overweight and Obesity. Clin Chem. 2018 Jan;64(1):99-107. doi: 10.1373/clinchem.2017.272443. Epub 2017 Nov 20.
- Hebert-Losier K, Wessman C, Alricsson M, Svantesson U. Updated reliability and normative values for the standing heel-rise test in healthy adults. Physiotherapy. 2017 Dec;103(4):446-452. doi: 10.1016/j.physio.2017.03.002. Epub 2017 Mar 21.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FeelWell2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
Linkoeping UniversityRecruiting
Clinical Trials on FeelWell™ Compression garment
-
University Hospital Schleswig-HolsteinCompleted
-
University of Colorado, DenverNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Recruiting
-
University of Colorado, DenverColorado Joint Replacement; mediCompleted
-
Hôpital Raymond PoincaréUnknownHypermobility Type Ehlers-Danlos SyndromeFrance
-
University of CalgaryCompleted
-
Nationwide Children's HospitalCompletedSyncope | Postural Orthostatic Tachycardia Syndrome (POTS)United States
-
University of OklahomaTerminated
-
Violeta Pajero OteroHospital Universitario 12 de Octubre; University of Castilla-La ManchaCompletedBreast Cancer LymphedemaSpain
-
Fundació Institut de Recerca de l'Hospital de la...CompletedBreast Cancer | Lymphedema | Rehabilitation | Prevention
-
BSN Medical GmbHCompletedProduct Use IssueGermany